Differential genotoxic effects of antitumor trans-[PtCl(2)(E-iminoether)(2)] and cisplatin in Escherichia coli
- PMID: 12031808
- DOI: 10.1016/s0162-0134(02)00403-8
Differential genotoxic effects of antitumor trans-[PtCl(2)(E-iminoether)(2)] and cisplatin in Escherichia coli
Abstract
In the present work, we measured survival and the platinum on the genome after treatment of repair-proficient or repair-deficient Escherichia coli strains with trans-[PtCl(2)(E-iminoether)(2)] and compared these results with the effects of "classical" cisplatin. We found that toxicity of antitumor trans-[PtCl(2)(E-iminoether)(2)] in repair-deficient trains was much less than that of cisplatin. This markedly reduced toxicity was not a consequence of the reduced uptake or low levels of DNA binding in the bacteria cells but rather appeared to reflect DNA binding mode of this trans-platinum drug different from that of cisplatin.
Similar articles
-
DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.Biochemistry. 2003 May 27;42(20):6321-32. doi: 10.1021/bi0342315. Biochemistry. 2003. PMID: 12755637
-
DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.Nucleic Acids Res. 2003 Nov 15;31(22):6450-60. doi: 10.1093/nar/gkg863. Nucleic Acids Res. 2003. PMID: 14602903 Free PMC article.
-
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands.J Inorg Biochem. 1999 Oct;77(1-2):31-5. doi: 10.1016/s0162-0134(99)00139-7. J Inorg Biochem. 1999. PMID: 10626350
-
DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.Prog Nucleic Acid Res Mol Biol. 2002;71:1-68. doi: 10.1016/s0079-6603(02)71040-4. Prog Nucleic Acid Res Mol Biol. 2002. PMID: 12102553 Review.
-
Trans-platinum complexes as anticancer drugs: recent developments and future prospects.Curr Med Chem. 2002 Sep;9(17):1611-8. doi: 10.2174/0929867023369376. Curr Med Chem. 2002. PMID: 12171556 Review.
Cited by
-
Solution behaviour and biological activity of bisamidine complexes of platinum(II).J Biol Inorg Chem. 2007 May;12(4):477-93. doi: 10.1007/s00775-006-0202-x. Epub 2007 Jan 9. J Biol Inorg Chem. 2007. PMID: 17211629
-
Bacterial Cytological Profiling Reveals the Mechanism of Action of Anticancer Metal Complexes.Mol Pharm. 2018 Aug 6;15(8):3404-3416. doi: 10.1021/acs.molpharmaceut.8b00407. Epub 2018 Jun 30. Mol Pharm. 2018. PMID: 29865789 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources